https://www.statnews.com/2020/06/24/yumanity-therapeutics-merck-strike-deal-aimed-at-developing-new-medicines-for-neurodegenerative-disease/?utm_source=STAT+Newsletters&utm_campaign=4d6f649b22-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-4d6f649b22-149692869

STAT Plus: Yumanity Therapeutics, Merck strike deal aimed at developing new medicines for neurodegenerative disease

By ADAM FEUERSTEIN

Merck is licensing two Yumanity research programs with the goal of identifying novel treatments for ALS and frontotemporal lobar dementia

READ MORE